Factorytalk had an exciting and engaging presence at the ISPE Australasia Digital Innovation Conference on 24-25 September 2024. We were honored to participate as speakers and panelists, sharing our expertise in digital transformation within the pharmaceutical industry.
Speaker Session: “GxP Digitalization at Scale with Composable Low Code / No-Code Software”
Manuh Pitasari, Lead Consultant, Manufacturing and Quality Solution at Factorytalk, and Bob Buhlmann, Head of Digital and Computer System Quality at AstraZeneca, presented a session on the benefits of no-code/low-code platforms in GxP-regulated environments. They shared insights into the innovative work we’ve been doing alongside Tulip Interfaces over the last few years, exploring the benefits of no-code/low-code solutions in the pharmaceutical sector.
Key takeaways from the presentation included:
1.Accelerating Development Cycles
No-code platforms enable faster prototyping and deployment of applications without requiring coding skills. This empowers “citizen developers” to create apps, significantly reducing IT backlogs and development costs.
2.Cost Efficiency and Flexibility
The ability to create and modify applications easily allows businesses to save time and money while adapting quickly to changing operational needs. No-code platforms are particularly effective at digitizing processes still reliant on paper or spreadsheets.
3.Compliance in GxP Environments
While no-code solutions offer agility, ensuring data integrity and compliance in GxP-regulated industries requires a robust validation process. A lean, risk-based validation approach was highlighted as critical to maintaining both flexibility and compliance.
4.Challenges of Scaling No-Code Solutions
Scaling these platforms requires careful governance to prevent duplication of systems, maintain validation controls, and ensure global standardization while allowing local customization.
Panel Discussion: “Potential Wins and Pitfalls with Innovation”
In addition to the speaker session, Factorytalk participated in a panel discussion that explored both the opportunities and challenges associated with digital transformation in regulated environments. The conversation emphasized the importance of balancing innovation with compliance, governance, and validation.
Booth Highlights
We were thrilled to showcase our innovative solutions at our booth, where we demonstrated how our products, can drive efficiency and compliance for pharmaceutical companies. We appreciated the opportunity to engage with attendees and discuss their unique digital transformation needs.
Thank you to everyone who visited our booth and joined our sessions. We look forward to continuing these exciting conversations.
